Home » Psychology news » Drug for Lou Gehrig’s disease boosts radiation effectiveness in melanoma laboratory models with brain metastasis
Drug for Lou Gehrig’s disease boosts radiation effectiveness in melanoma laboratory models with brain metastasis
January 12, 2015 by NewsBot
A drug used to treat Lou Gehrig's disease (ALS) helps radiation be more effective when it was administered to laboratory models with melanoma that had metastasized to the brain, researchers have demonstrated.